Challenging T > MIC Using Meropenem vs. Escherichia coli and Pseudomonas aeruginosa

A Nussbaumer-Pröll1, S Eberl1, E Kurdina1

  • 1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Insights

Dividing meropenem exposure time (40%T > MIC) into three doses enhanced bacterial killing and reduced resistance emergence in P. aeruginosa in vitro. This dosing strategy proved more effective than single or double doses for optimal antimicrobial activity.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Meropenem's efficacy against P. aeruginosa and E. coli is linked to 40%T > MIC.
  • The impact of %T > MIC distribution on antimicrobial effect in vitro remains unclear.

Purpose of the Study:

  • To investigate the in vitro antibiotic activity of meropenem based on %T > MIC distribution.
  • To compare the efficacy of single, double, and triple dosing regimens of meropenem in achieving 40%T > MIC.

Main Methods:

  • Time kill curves (TKC) were performed with P. aeruginosa and E. coli isolates.
  • Simulated different dosing regimens (single, double, triple) to maintain a constant 40%T > MIC.
  • Evaluated bacterial killing, inoculum effect, and emergence of phenotypical resistance.

Main Results:

  • Triple dosing of meropenem showed the best bacterial killing for P. aeruginosa and E. coli.
  • A minimum concentration of 4×MIC was required for significant bacterial reduction in multiple regimens.
  • Resistance emerged in P. aeruginosa across all regimens, most pronounced with single dosing; no resistance emerged in E. coli.

Conclusions:

  • The distribution of %T > MIC, not just the duration, is crucial for efficient bacterial eradication in vitro.
  • Dividing 40%T > MIC into three doses enhances killing and reduces resistance emergence in P. aeruginosa.
  • Dosing strategy may significantly impact outcomes with intermediate or resistant pathogens.